https://www.selleckchem.com/pr....oducts/iberdomide.ht
of ALAS. TRIAL REGISTRATION Clinical Research Information Service (cris.nih.go.kr), KCT0002257. Registered on 27 February 2017.BACKGROUND In three randomized, controlled laboratory efficacy studies, the efficacy in the prevention of patent infections of a topical combination of imidacloprid 10%/moxidectin 1% (Advocate® spot-on formulation for cats, Bayer Animal Health GmbH) against larval stages and immature adults of Aelurostrongylus abstrusus, as well as the treatment efficacy of a single or three monthly treatments against adult A
Like
Comment
Share
